Cardiac technology developer St. Jude Medical has launched its Ilumien Optis system in Japan, a technology designed to help physicians make personalized stenting decisions based on a patient's individual anatomy and disease state.
The Ilumien Optis system combines fractional flow reserve (FFR) data and intravascular optical coherence tomography (OTC) in a single imaging platform. The system provides a physiological and anatomical view of the coronary vessels to help diagnose and treat coronary artery disease, according to St. Jude.
To measure FFR, the system uses the company's PressureWire Aeris wireless technology, which collects analyses of blood flow blockages in the coronary vessels to help determine which specific blockages are causing the patient's blood flow to be ineffective. The FFR pressure guidewire is directed through the coronary arteries and across the narrowed vessel, taking measurements as the guidewire is pulled back through the narrowed part of the artery.
The OCT technology in the Ilumien Optis system uses a Dragonfly JP imaging catheter to capture near-infrared light imaging and measure important vessel characteristics. New high-resolution settings and real-time 3D reconstruction provide a 360° panoramic view of the vessel.
